Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57121853Aexternal-prioritypatent/JPS5913714A/en
Application filed by PfizerfiledCriticalPfizer
Publication of MY100229ApublicationCriticalpatent/MY100229A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
A NOVEL FORMULATION OF PIROXICAM FOR DERMATOLOGICAL ADMINISTRATION IS DISCLOSED. PHARMACEUTICAL COMPOSITIONS CONTAINING PIROXICAM, LOWER ALKANOLS, WATER, CARBOXYVINYL POLYMER, POLYHYDRIC ALCOHOLS, ALKANOLAMINES AND OPTIONALLY FILM-FORMING AGENTS ARE PREPARED, SAID COMPOSITIONS HAVING A pH OF FROM ABOUT 6.5 TO ABOUT 9.0. THE NOVEL FORMULATION IS CHARACTERIZED BY EXCELLENT APPLICABILITY ON THE SKIN, SKIN-PERMEABILITY AND GOOD STABILITY.THE NOVEL FORMULATION, WHICH IS IN GEL OINTMENT FORM, IS AS EFFECTIVE AS ORALLY ADMINISTERED PIROXICAM AND IS WELL SUITED FOR TOPICAL ADMINISTRATION THROUGH SKIN FOR THE TREATMENT OF VARIOUS TYPES OF INFLAMMATORY CONDITIONS.